Category Archives: Uncategorized

Poll: D.C. voters poised to legalize pot, elevating national debate over marijuana

Washington, D.C., voters appear to be ready to legalize marijuana, according to a new poll that puts support at 65 percent.

The NBC4/Washington Post/Marist poll’s finding that district voters support legalization by amost a 2-1 margin “is the highest support ever for a marijuana legalization ballot initiative,” Adam Eidinger, chair of D.C. Cannabis Campaign, the group backing the legalization measure, said in a statement. “It vindicates the work of this campaign so far, but we still have more work to do turning out the vote come Election Day.”

On Nov. 4, D.C. voters will decide Initiative 71, which would legalize adult marijuana use, possession of up to two ounces, and home cultivation of up to six marijuana plants for personal use. The sale of marijuana would remain illegal. The D.C. Council is considering a separate bill that would allow the regulation and taxation of marijuana.

The new poll suggests D.C. will join Washington state and Colorado in legalizing recreational marijuana. Just days before Washington state voters legalized recreational marijuana in 2012, Public Policy Polling found 53 percent support for the measure. The day before Colorado voters approved marijuana for recreational use by adults, PPP found 52 percent support.

“Voters are relating to the message that legalization will end D.C.’s rampant discrimination when it comes marijuana enforcement,” said Dr. Malik Burnett, D.C. Policy Manager for the Drug Policy Alliance, in a statement.

According to the Washington Lawyers’ Committee, arrest statistics from 2009 to 2011 revealed that nine out of 10 people arrested for drugs in Washington were black, though blacks make up just slightly more than half of the city’s population. Yet government surveys show that blacks are no more likely than whites to use the drug.

A marijuana activist criticized The Washington Post for editorializing against legalization.

“At the very moment this Washington Post poll was in the field, the paper’s own editorial board was circulating a ‘Reefer Madness’-style, error-laden screed urging D.C. voters to reject legalization,” Marijuana Majority’s Tom Angell told The Huffington Post. A Sunday Post editorial urged D.C. voters to “reject the rush to marijuana.”

“It looks like that didn’t work,” Angell said of the editorial. “No matter how hard prohibitionists try to spread scare stories about legalization, poll after poll confirms that this is a mainstream issue supported by a growing majority of the public.”

Kevin Sabet, co-founder of anti-legalization group Project SAM, said he sees the poll numbers differently.

“I think it represents the fact that the ‘Yes’ side has spent hundreds of thousands of dollars raised outside the District on its messaging,” Sabet said. “As voters hear more about why marijuana and marijuana businesses are not good for the District, I expect the gap to narrow.”

The ballot measure builds on several recent moves to remove restrictions on marijuana in Washington. The District’s first medical marijuana dispensary opened last year. Earlier this year, the D.C. Council decriminalized the possession of an ounce or less of marijuana. The District legalized marijuana for medical use in 2010. Twenty-three states also have legalized medical marijuana.

Voters in three states will decide on new marijuana laws in November. Oregon and Alaska voters will cast ballots on the legalization of recreational marijuana, while voters in Florida will decide on a medical marijuana ballot measure.

Bill to Add PTSD to New Jersey Medical Marijuana Program Filed in Assembly

Jay Leiderman, Ventura's Premier Marijuana Lawyer

TRENTON, NJ — A bill to add post-traumatic stress disorder, or PTSD, to the list of qualifying conditions for medical marijuana in New Jersey was filed Monday.

The bill, Assembly Bill 3726, is sponsored by Vincent Mazzeo (D-Atlantic) and Linda Stender (D-Middlesex, Somerset and Union).

Post-traumatic stress disorder is an anxiety disorder that is estimated to impact some eight million Americans annually, including many military veterans returning from combat as well as victims of violent crimes, such as rape.

READ MORE

💻📧📱🌇🎰✅🍁
Ventura’s Best Lawyer
Jay Leiderman
Please visit my homepage
JayLeiderman.com
5740 Ralston St 300
Ventura, California 93003
805-654-0200
Jay@criminal-lawyer.me

IMG_0099.JPG

View original post

Americans Favor Legalization of Marijuana as Elections Approach

In All Factuality

The midterm elections are approaching quickly and reforming marijuana laws is a major issue on the ballot this year.  Stephen Gutwillig reviews some of the issues, state by state, in his article 9 Crucial Ballot Measures that Could Legalize Marijuana and Help End the Drug War this Election.  

According to Gutwillig, the American public is largely in favor of the legalization of marijuana coming into the elections.

His claim: 

“Public opinion has shifted dramatically over the last decade in favor of reforming marijuana laws and dismantling the egregious excesses of the drug war.”

Gutwillig may hold some bias regarding the war on drugs.  He is the Deputy Executive Director for Programs of the Drug Policy Alliance, the “nation’s leading organization working to promote alternatives to the failed war on drugs.”

Because of his connection to the Drug Policy Alliance, I was a bit skeptical of his statement…

View original post 414 more words

CBD Associated With Improved Quality Of Life In Patients With Parkinson’s

By Paul Armentano, NORML Deputy Director

The administration of cannabidiol (CBD), a nonpsychotropic cannabinoid, is associated with improved quality of life in patients with Parkinson’s disease, according clinical trial data published online ahead of print in the Journal of Psychopharmacology.

Investigators at the University of São Paulo in Brazil assessed the efficacy of CBD versus placebo in 21 subjects with Parkinson’s. Authors reported that the administration of 300 mg doses of CBD per day was associated with “significantly different mean total scores” in subjects’ well-being and quality of life compared to placebo.

Separate assessments of CBD versus placebo reported that the cannabinoid did not appear to mitigate general symptoms of the disease, nor was it shown to be neuroprotective.

“This study points to a possible effect of CBD in improving measures related to the quality of life of PD patients without psychiatric comorbidities,” investigators concluded. They added, “We found no statistically significant differences concerning the motor symptoms of PD; however, studies involving larger samples and with systematic assessment of specific symptoms of PD are necessary in order to provide stronger conclusions regarding the action of CBD in PD.”

Clinical reports have previously indicated that both CBD and/or whole-plant cannabis may address various symptom’s of Parkinson’s disease, including improvement in motor symptoms, pain reduction, improved sleep, and a reduction in the severity of psychotic episodes.

Survey data of patients with PD indicates that almost half of all subjects who try cannabis report experiencing subjective relief from the plant.

The abstract of the study, “Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial,” appears online here.